Western Europe (EU-16) In Vitro Diagnostics Market Report & Forecast (2012 – 2015)
In Western Europe (EU-16) countries major portion of healthcare is borne by the government. These Western Europe (EU-16) countries spend 9 to 11% of their GDP on the healthcare of its citizens. So the recent Euro zone crisis has hardly hit the In Vitro Diagnostics (IVD) market for the year 2011 and 2012. But from 2013 the growth for In Vitro Diagnostics (IVD) industry is expected to be back on track. Western Europe (EU-16) In Vitro Diagnostics (IVD) market is one of the biggest markets globally. Western Europe (EU-16) In Vitro Diagnostics (IVD) market is expected to be more than Euro 11 Billion by 2015.
Germany, France and Italy are three biggest markets in Western European (EU-16) countries. Germany controls the biggest market share closely followed by France and Italy in 2011. Together these three countries controls 58.5% market share for the year 2011. From our research we found that only two countries out of 16 countries studied in this report is expected to show a contraction in In Vitro Diagnostics (IVD) market for the year 2012. Whereas rest of the Western Europe (EU-16) countries will either grow marginal or will show no growth for the year 2012. However from 2013 every country is expected to back on track and expected to grow.
Renub Research report entitled “Western Europe (EU-16) In Vitro Diagnostics Market Report & Forecast (2012 – 2015)” provides a comprehensive assessment of the 16 Western European countries In Vitro Diagnostics (IVD) market scenario and its forecast. The report also provides market landscape and market share information in the Western Europe (EU-16) IVD market. The report also entails major drivers and challenges of Western Europe (EU-16) In Vitro Diagnostics market.
Countries Analyzed in this Report
Germany, France, Italy, United Kingdom, Spain, Netherlands, Greece, Portugal, Belgium, Sweden, Austria, Denmark, Finland, Ireland, Switzerland, Norway
Key Topics Covered in the Report
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 100 paid databases.
Germany, France and Italy are three biggest markets in Western European (EU-16) countries. Germany controls the biggest market share closely followed by France and Italy in 2011. Together these three countries controls 58.5% market share for the year 2011. From our research we found that only two countries out of 16 countries studied in this report is expected to show a contraction in In Vitro Diagnostics (IVD) market for the year 2012. Whereas rest of the Western Europe (EU-16) countries will either grow marginal or will show no growth for the year 2012. However from 2013 every country is expected to back on track and expected to grow.
Renub Research report entitled “Western Europe (EU-16) In Vitro Diagnostics Market Report & Forecast (2012 – 2015)” provides a comprehensive assessment of the 16 Western European countries In Vitro Diagnostics (IVD) market scenario and its forecast. The report also provides market landscape and market share information in the Western Europe (EU-16) IVD market. The report also entails major drivers and challenges of Western Europe (EU-16) In Vitro Diagnostics market.
Countries Analyzed in this Report
Germany, France, Italy, United Kingdom, Spain, Netherlands, Greece, Portugal, Belgium, Sweden, Austria, Denmark, Finland, Ireland, Switzerland, Norway
Key Topics Covered in the Report
- Western Europe (EU-16) In Vitro Diagnostics Market Performance (2005 - 2011)
- Western Europe (EU-16) In Vitro Diagnostics Market Forecast (2012 - 2015)
- Western Europe (EU-16) In Vitro Diagnostics Market Share (Country wise) (2009 - 2011)
- Western Europe (EU-16) In Vitro Diagnostics Market Share Forecast (Country wise) (2012 - 2015)
- Western Europe (EU-16) Market Performance of In Vitro Diagnostics Market for Each Country (2002 – 2011)
- Western Europe (EU-16) Market Forecast of In Vitro Diagnostics Market for Each Country (2012 – 2015)
- Drivers and Challenges for Western Europe (EU-16) In Vitro Diagnostics Market
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 100 paid databases.
1. EXECUTIVE SUMMARY
2. WESTERN EUROPE (EU–16) – IN VITRO DIAGNOSTICS MARKET (2005 – 2015)
3. WESTERN EUROPE (EU–16) – IN VITRO DIAGNOSTICS MARKET SHARE & FORECAST
4. GEOGRAPHICAL SEGMENTATION OF WESTERN EUROPE (EU–16) IN VITRO DIAGNOSTICS MARKET
4.1 Germany – In Vitro Diagnostics Market & Forecast
4.2 France – In Vitro Diagnostics Market & Forecast
4.3 Italy – In Vitro Diagnostics Market & Forecast
4.4 United Kingdom – In Vitro Diagnostics Market & Forecast
4.5 Spain – In Vitro Diagnostics Market & Forecast
4.6 Netherlands – In Vitro Diagnostics Market & Forecast
4.7 Greece – In Vitro Diagnostics Market & Forecast
4.8 Portugal – In Vitro Diagnostics Market & Forecast
4.9 Belgium – In Vitro Diagnostics Market & Forecast
4.10 Sweden – In Vitro Diagnostics Market & Forecast
4.11 Austria – In Vitro Diagnostics Market & Forecast
4.12 Denmark – In Vitro Diagnostics Market & Forecast
4.13 Finland – In Vitro Diagnostics Market & Forecast
4.14 Ireland – In Vitro Diagnostics Market & Forecast
4.15 Switzerland – In Vitro Diagnostics Market & Forecast
4.16 Norway – In Vitro Diagnostics Market & Forecast
5. WESTERN EUROPE (EU–16) IN VITRO DIAGNOSTICS MARKET GROWTH DRIVERS
5.1 EDMA & Eucomed Commit to Providing Solutions to Achieve a Healthy Future for Europe
5.2 Companion Diagnostics & Personalized Medicine: A Revolution of Knowledge in European Healthcare
6. WESTERN EUROPE (EU–16) IN VITRO DIAGNOSTICS MARKET CHALLENGES
6.1 Western Europe IVD Manufacturers are Experiencing Difficulties Navigating for Labeling & Language Requirements
6.2 Market Access Challenges in the Western Europe for High Medical Value Diagnostic Tests
6.2.1 Germany
6.2.2 France
6.3 Upcoming IVD Changes for EU Market Will Increase Costs for Medical Device Companies
2. WESTERN EUROPE (EU–16) – IN VITRO DIAGNOSTICS MARKET (2005 – 2015)
3. WESTERN EUROPE (EU–16) – IN VITRO DIAGNOSTICS MARKET SHARE & FORECAST
4. GEOGRAPHICAL SEGMENTATION OF WESTERN EUROPE (EU–16) IN VITRO DIAGNOSTICS MARKET
4.1 Germany – In Vitro Diagnostics Market & Forecast
4.2 France – In Vitro Diagnostics Market & Forecast
4.3 Italy – In Vitro Diagnostics Market & Forecast
4.4 United Kingdom – In Vitro Diagnostics Market & Forecast
4.5 Spain – In Vitro Diagnostics Market & Forecast
4.6 Netherlands – In Vitro Diagnostics Market & Forecast
4.7 Greece – In Vitro Diagnostics Market & Forecast
4.8 Portugal – In Vitro Diagnostics Market & Forecast
4.9 Belgium – In Vitro Diagnostics Market & Forecast
4.10 Sweden – In Vitro Diagnostics Market & Forecast
4.11 Austria – In Vitro Diagnostics Market & Forecast
4.12 Denmark – In Vitro Diagnostics Market & Forecast
4.13 Finland – In Vitro Diagnostics Market & Forecast
4.14 Ireland – In Vitro Diagnostics Market & Forecast
4.15 Switzerland – In Vitro Diagnostics Market & Forecast
4.16 Norway – In Vitro Diagnostics Market & Forecast
5. WESTERN EUROPE (EU–16) IN VITRO DIAGNOSTICS MARKET GROWTH DRIVERS
5.1 EDMA & Eucomed Commit to Providing Solutions to Achieve a Healthy Future for Europe
5.2 Companion Diagnostics & Personalized Medicine: A Revolution of Knowledge in European Healthcare
6. WESTERN EUROPE (EU–16) IN VITRO DIAGNOSTICS MARKET CHALLENGES
6.1 Western Europe IVD Manufacturers are Experiencing Difficulties Navigating for Labeling & Language Requirements
6.2 Market Access Challenges in the Western Europe for High Medical Value Diagnostic Tests
6.2.1 Germany
6.2.2 France
6.3 Upcoming IVD Changes for EU Market Will Increase Costs for Medical Device Companies
LIST OF FIGURES
Figure 2 1: Western Europe (EU-16) – In Vitro Diagnostics Market (Million Euro), 2005 – 2011
Figure 2 2: Western Europe (EU-16) – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 1: Germany – In Vitro Diagnostics Market (Million Euro), 2002 – 2011
Figure 4 2: Germany – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 3: France – In Vitro Diagnostics Market (Million Euro), 2002 – 2011
Figure 4 4: France – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 5: Italy – In Vitro Diagnostics Market (Million Euro), 2002 – 2011
Figure 4 6: Italy – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 7: United Kingdom – In Vitro Diagnostics Market (Million Euro), 2002 – 2011
Figure 4 8: United Kingdom – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 9: Spain – In Vitro Diagnostics Market (Million Euro), 2002 – 2011
Figure 4 10: Spain – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 11: Netherlands – In Vitro Diagnostics Market (Million Euro), 2002 – 2011
Figure 4 12: Netherlands – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 13: Greece – In Vitro Diagnostics Market (Million Euro), 2002 – 2011
Figure 4 14: Greece – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 15: Portugal – In Vitro Diagnostics Market (Million Euro), 2002 – 2011
Figure 4 16: Portugal – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 17: Belgium – In Vitro Diagnostics Market (Million Euro), 2002 – 2011
Figure 4 18: Belgium – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 19: Sweden – In Vitro Diagnostics Market (Million Euro), 2005 – 2011
Figure 4 20: Sweden – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 21: Austria – In Vitro Diagnostics Market (Million Euro), 2002 – 2011
Figure 4 22: Austria – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 23: Denmark – In Vitro Diagnostics Market (Million Euro), 2005 – 2011
Figure 4 24: Denmark – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 25: Finland – In Vitro Diagnostics Market (Million Euro), 2002 – 2011
Figure 4 26: Finland – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 27: Ireland – In Vitro Diagnostics Market (Million Euro), 2005 – 2011
Figure 4 28: Ireland – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 29: Switzerland – In Vitro Diagnostics Market (Million Euro), 2002 – 2011
Figure 4 30: Switzerland – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 31: Norway – In Vitro Diagnostics Market (Million Euro), 2005 – 2011
Figure 4 32: Norway – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 6 1: Toxicity Challenge Associated with the Current Drug-Development Model (2011)
Figure 6 2: Efficacy Challenge Associated with the Current Drug-Development Model (Percent), 2011
Figure 6 3: Germany – Healthcare System Map
Figure 2 1: Western Europe (EU-16) – In Vitro Diagnostics Market (Million Euro), 2005 – 2011
Figure 2 2: Western Europe (EU-16) – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 1: Germany – In Vitro Diagnostics Market (Million Euro), 2002 – 2011
Figure 4 2: Germany – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 3: France – In Vitro Diagnostics Market (Million Euro), 2002 – 2011
Figure 4 4: France – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 5: Italy – In Vitro Diagnostics Market (Million Euro), 2002 – 2011
Figure 4 6: Italy – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 7: United Kingdom – In Vitro Diagnostics Market (Million Euro), 2002 – 2011
Figure 4 8: United Kingdom – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 9: Spain – In Vitro Diagnostics Market (Million Euro), 2002 – 2011
Figure 4 10: Spain – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 11: Netherlands – In Vitro Diagnostics Market (Million Euro), 2002 – 2011
Figure 4 12: Netherlands – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 13: Greece – In Vitro Diagnostics Market (Million Euro), 2002 – 2011
Figure 4 14: Greece – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 15: Portugal – In Vitro Diagnostics Market (Million Euro), 2002 – 2011
Figure 4 16: Portugal – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 17: Belgium – In Vitro Diagnostics Market (Million Euro), 2002 – 2011
Figure 4 18: Belgium – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 19: Sweden – In Vitro Diagnostics Market (Million Euro), 2005 – 2011
Figure 4 20: Sweden – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 21: Austria – In Vitro Diagnostics Market (Million Euro), 2002 – 2011
Figure 4 22: Austria – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 23: Denmark – In Vitro Diagnostics Market (Million Euro), 2005 – 2011
Figure 4 24: Denmark – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 25: Finland – In Vitro Diagnostics Market (Million Euro), 2002 – 2011
Figure 4 26: Finland – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 27: Ireland – In Vitro Diagnostics Market (Million Euro), 2005 – 2011
Figure 4 28: Ireland – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 29: Switzerland – In Vitro Diagnostics Market (Million Euro), 2002 – 2011
Figure 4 30: Switzerland – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 4 31: Norway – In Vitro Diagnostics Market (Million Euro), 2005 – 2011
Figure 4 32: Norway – Forecast for In Vitro Diagnostics Market (Million Euro), 2012 – 2015
Figure 6 1: Toxicity Challenge Associated with the Current Drug-Development Model (2011)
Figure 6 2: Efficacy Challenge Associated with the Current Drug-Development Model (Percent), 2011
Figure 6 3: Germany – Healthcare System Map
LIST OF TABLES
Table 3 1: Western Europe (EU -16) – In Vitro Diagnostics Market Share (Percent), 2009 – 2011
Table 3 2: Western Europe (EU -16) – Forecast for In Vitro Diagnostics Market Share (Percent), 2012 – 2015
Table 6 1: European Language Requirements (EU and EEA)
Table 3 1: Western Europe (EU -16) – In Vitro Diagnostics Market Share (Percent), 2009 – 2011
Table 3 2: Western Europe (EU -16) – Forecast for In Vitro Diagnostics Market Share (Percent), 2012 – 2015
Table 6 1: European Language Requirements (EU and EEA)
